Insmed Inc. buy Barclays PLC
Start price
29.05.24
/
50%
€43.00
Target price
29.05.25
€58.07
Performance (%)
43.02%
End price
30.05.25
€61.50
Summary
This prediction ended on 30.05.25 with a price of €61.50. With a performance of 43.02% the BUY prediction by Barclays_PLC was a big success. Barclays_PLC has a follow-up prediction for Insmed Inc. where he still thinks Insmed Inc. is a Buy. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Insmed Inc. | -3.400% | -3.400% | 2.611% |
| iShares Core DAX® | -1,06 % | 5,01 % | 6,60 % |
| iShares Nasdaq 100 | -2,39 % | 0,86 % | 25,79 % |
| iShares Nikkei 225® | -4,36 % | 1,21 % | 41,31 % |
| iShares S&P 500 | -1,78 % | 1,39 % | 21,04 % |
Comments by Barclays_PLC for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Barclays PLC from $40.00 to $63.00. They now have an "overweight" rating on the stock.
Ratings data for INSM provided by MarketBeat
In the thread Trading Insmed Inc.
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten